ELSE NUTRITION ANNOUNCES SHARE CONSOLIDATION

ELSE NUTRITION ANNOUNCES SHARE CONSOLIDATION

Else Nutrition Holdings Inc. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) (the "Company") announces that the Company's board of directors has approved a consolidation of the Company's common shares on the basis of one (1) post-consolidation common share for every ten (10) pre-consolidation common shares. The Company's common shares are expected to commence trading on the Toronto Stock Exchange on a post-share consolidation basis at market opening on November 6, 2025.

The common shares will continue to be listed on the TSX under the symbol "BABY" on a post-consolidation basis under the new CUSIP and new ISIN numbers, 290257500 and CA2902575000, respectively.

As a result of the share consolidation the number of issued and outstanding common shares of the Company will be reduced from 374,114,284 pre-consolidation common shares to approximately 37,411,430 post-consolidation common shares, subject to adjustments for rounding. Proportionate adjustments have been made to the Company's outstanding stock options, warrants, and other convertible securities. No fractional common shares will be issued as a result of the share consolidation. Any fractional interest in common shares that is less than 0.5 of a common share resulting from the share consolidation will be rounded down to the nearest whole common share, and any fractional interest in common shares that is equal to or greater than 0.5 of a common share will be rounded up to the nearest whole common share.

The Company's registered shareholders holding their common shares in certificated form will receive a letter of transmittal from Computershare Investor Services Inc., the Company's transfer agent, in respect to the share consolidation, which each registered shareholder will need to sign and complete. The letter of transmittal will contain instructions to registered shareholders on how to surrender the certificates representing their pre-consolidation common shares and authorize Computershare to issue a direct registration advice(s) (DRS) representing their post-consolidation common shares. The Company's registered shareholders whose common shares are represented by a DRS statement will not be required to complete and sign a letter of transmittal, and a DRS statement representing their post-consolidation common shares will automatically be issued to those registered shareholder by Computershare.

Non-registered shareholders who hold their common shares through an intermediary such as a bank, trust company, securities dealer or broker should note that these intermediaries may have their own procedures for processing the share consolidation which may differ from those described above for registered shareholders. Non-registered shareholders who have questions should contact their intermediary for more information.

Registered holders of the Company's warrants issued on October 20, 2021, will be given notice of the effect of the share consolidation pursuant to the Warrant Indenture dated October 20, 2021 between the Company and Computershare. Registered holders of the Company's warrants issued on June 29, 2022, will be given notice of the effect of the share consolidation pursuant to the Warrant Indenture dated June 29, 2022.

About Else Nutrition Holdings Inc.

Else Nutrition Holdings Inc. is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.

Awards and Recognition:

  • "2017 Best Health and Diet Solutions" award at Milan's Global Food Innovation Summit
  • #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category
  • "Best Dairy Alternative" Award 2021 at World Plant-Based Expo
  • Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category
  • During September 2022, Else Super Cereal reached the #1 Best Seller in Baby Cereal across all brands on Amazon

For more information, visit www.elsenutrition.com or @elsenutrition on Facebook and Instagram.

Caution Regarding Forward-Looking Statements 

This news release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this news release include but are not limited to, statements relating to current intent, belief, and expectations with respect to: the trading of the post-consolidation shares on the TSX and the expected timing thereof, the number of post-consolidation shares following the share consolidation, and the timing and process for issuing post-consolidation shares. These forward-looking statements are made as of the date of this news release. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. Although the Company believes the forward-looking statements in this news release are reasonable, it can give no assurance that the expectations and assumptions in such statements will prove to be correct. The Company cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and are subject to risks, uncertainties, assumptions and other factors which could cause events or outcomes to differ materially from those expressed or implied by such forward-looking statements. Such factors and assumptions include, among others, variations in market conditions; currency exchange rates; the Company's ability to obtain any necessary permits, consents or authorizations required for its activities; the Company's ability to access further funding, to continue its projected growth, or to be fully able to implement its business strategies. In addition, there are known and unknown risk factors which could cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.  Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this news release.  The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/else-nutrition-announces-share-consolidation-302603127.html

SOURCE Else Nutrition Holdings Inc.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2025/03/c9315.html

News Provided by Canada Newswire via QuoteMedia

BABYF
The Conversation (0)
Life Sciences Virtual Investor Conference Agenda Announced for September 15th

Life Sciences Virtual Investor Conference Agenda Announced for September 15th

Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Life Sciences Virtual Investor Conference to be held on September 15 th . Individual investors, institutional investors, advisors, and analysts are invited to attend this... Keep Reading...

Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

Life Sciences Investor Forum today announced that the presentations from the September 16 th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live executive presentations and interactive discussions focused on publicly traded... Keep Reading...

Life Sciences Virtual Investor Conference: Company Executives Present Live September 16th

Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors, and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life... Keep Reading...

Growth Company Investor Presentations Now Available for On-Demand Viewing

Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the Growth Opportunities Virtual... Keep Reading...

Live Growth Opportunities Investor Conference October 8th

Company executives will share vision and answer audience questions at VirtualInvestorConferences.com Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Growth Opportunities Virtual lnvestor Conference. Individual... Keep Reading...

Latest Press Releases

Related News